Skip to content
Menu
Home
Science
Changing the Narrative
BXQ-350 MOA
mCRC
CIPN
Pediatrics
Pipeline
Clinical Trials
About Bexion
Executive Team
Board of Directors
Scientific Advisors
Key Milestones
Advocacy Partners
Media & Press
Press Releases
Resources
Video Library
Abstracts
Posters
Case Studies
Investors & Partners
Corporate Profile
Events
Home
neptuneweb
2023-01-09T11:42:12-05:00
Poised to Deliver Breakthroughs in Oncology and CNS
BXQ-350: NOVEL S1P REDUCTION PROPERTIES, TARGETED, DIFFERENT
Learn more
Page load link
Go to Top
